Impact of clopidogrel on bleeding complications and survival in off-pump coronary artery bypass grafting
Open Access
- 22 December 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 14 (3), 273-277
- https://doi.org/10.1093/icvts/ivr089
Abstract
This study investigated the impact of preoperative clopidogrel on bleeding complications and survival during and after off-pump coronary artery bypass grafting (OPCABG) and assessed the possible role of the antifibrinolytic agent aprotinin for attenuating blood loss after clopidogrel exposure. Prospectively collected data of 753 consecutive adult patients undergoing OPCABG were retrospectively reviewed; 139 (18.5%) patients received clopidogrel preoperatively. Statistical methods used were student paired t-test, Mann–Whitney U, Kruskal–Wallis, chi-square analysis and Kaplan–Meier with log-rank analysis. Clopidogrel was associated with a significant increase in perioperative blood loss (P = 0.003) and more excessive postoperative haemorrhage (P = 0.04). Overall transfusion rates (P = 0.02) and the amount of administered blood products (P = 0.01) were also higher after clopidogrel exposure. Intraoperative aprotinin reduced postoperative bleeding significantly in patients administered clopidogrel [18.7% after 24 h (P = 0.006) and 15.2% after 48 h (P = 0.03)] and attenuated excessive postoperative haemorrhaging. Five-year survival was markedly improved in clopidogrel-treated patients. Preoperative clopidogrel exposure does increase perioperative blood loss and blood transfusion requirements in patients undergoing OPCABG but has an otherwise excellent safety profile with a 94% 5-year survival rate. Aprotinin attenuated this blood loss. Based on these results a recommendation to discontinue clopidogrel prior to coronary artery bypass grafting cannot be maintained, if OPCABG strategies are considered.Keywords
This publication has 12 references indexed in Scilit:
- Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery DiseaseNew England Journal of Medicine, 2009
- Aprotinin for Patients Exposed to Clopidogrel before Off-Pump Coronary BypassAsian Cardiovascular and Thoracic Annals, 2008
- Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgeryEuropean Journal of Cardio-Thoracic Surgery, 2008
- The Impact of Aprotinin on Blood Loss and Blood Transfusion in Off-Pump Coronary Artery Bypass GraftingThe Annals of Thoracic Surgery, 2008
- A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac SurgeryNew England Journal of Medicine, 2008
- Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Impact of aspirin with or without clopidogrel on postoperative bleeding and blood transfusion in coronary surgical patients treated prophylactically with a low-dose of aprotininEuropean Heart Journal, 2007
- Effect of Clopidogrel Premedication in Off-Pump Cardiac SurgeryCirculation, 2006
- Off-pump versus on-pump coronary surgery: final results from a prospective randomized study Prague-4The Annals of Thoracic Surgery, 2004
- Blood Use in Patients Undergoing Coronary Artery Bypass Surgery: Impact Of Cardiopulmonary Bypass Pump, Hematocrit, Gender, Age, and Body WeightAnesthesia & Analgesia, 2003